Figure 3.
Figure 3. Outcomes among CB transplant and BM transplant recipients. (A) Probability of TRM. The 1-year cumulative incidence of TRM was 9% (95% CI, 2%-16%) among CB transplant recipients and 29% (95% CI, 15%-42%) among BM transplant recipients (P = .02). (B) Cumulative incidence of relapse. The 2-year probabilities of relapse among recipients were 16% (95% CI, 7%-25%) after CBT and 25% (95% CI, 12%-37%) after BMT. The difference between the 2 groups was not significant. (C) Kaplan-Meier estimate of DFS. The 2-year probabilities of DFS were 74% (95% CI, 63%-85%) after CBT and 44% (95% CI, 30%-59%) after BMT (P < .01).

Outcomes among CB transplant and BM transplant recipients. (A) Probability of TRM. The 1-year cumulative incidence of TRM was 9% (95% CI, 2%-16%) among CB transplant recipients and 29% (95% CI, 15%-42%) among BM transplant recipients (P = .02). (B) Cumulative incidence of relapse. The 2-year probabilities of relapse among recipients were 16% (95% CI, 7%-25%) after CBT and 25% (95% CI, 12%-37%) after BMT. The difference between the 2 groups was not significant. (C) Kaplan-Meier estimate of DFS. The 2-year probabilities of DFS were 74% (95% CI, 63%-85%) after CBT and 44% (95% CI, 30%-59%) after BMT (P < .01).

Close Modal

or Create an Account

Close Modal
Close Modal